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ABSTRACT 
 
 
 RBR (RING1-in between RING-RING2) is a special type of E3 ubiquitin ligase 
containing three zinc-binding RING (Really Interesting New Gene) domains, while 
adopting mechanisms of HECT (Homologous to E6-AP Carboxyl Terminus) for substrate 
ubiquitination. Most well known RBRs include Parkin and HOIP, which are associated 
with Parkinson’s disease and innate immune deficiency. However, it is not well known 
how the RBR proteins gain activity, as they are known to be autoinhibited. Here I show 
that a specific F430A, E431A, E503A triple mutation of RBR protein HHARI (Human 
homologue of Ariadne) and its interaction with NEDD8ylated cullin RING ligase can 
both boost its activity and stabilize complex formation. Analytical size-exclusion 
chromatography, autoubiquitination, and electron microscopy reveal consistent behavior 
for this triple-mutant. Future structure-based studies will help elucidate the mechanism of 
the unsolved mystery of RBR activation and its interaction with NEDD8ylated cullin 
RING ligases.  
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CHAPTER 1.    INTRODUCTION 
 
 
The Ubiquitin Pathway 
  
 Ubiquitination is a post-translational covalent modification of protein by a 76 
amino acid ubiquitin (Ub) forming an isopeptide bond between the ubiquitin C-terminal 
glycine residue 76 and the substrate lysine. Ubiquitin can form monoubiquitin or 
polyubiquitin chains linked by the N-terminal methionine or seven lysine residues (K6, 
K11, K27, K29, K33, K48, K63) and its C-terminus GG is a required for its covalent 
modification to proteins (Hodgins et al., 1992; Komander, 2009). Different types of 
polyubiquitin chains allow participation of substrates in many important processes 
including proteosomal/lysosomal degradation, transcription, signal transduction, and 
protein trafficking (Komander and Rape, 2012).  
 
In order to ubiquitinate target substrates, the pathway involves three sequential 
mechanisms (Figure 1-1). First, the C-terminus of ubiquitin must be activated by acyl-
adenylation in the presence of ATP and Mg2+. The catalytic cysteine of the E1 activating 
enzyme attacks the adenylated ubiquitin, producing a highly active E1~Ub thioester 
complex (Schulman and Harper, 2009). Then, the E2 ubiquitin conjugating enzyme 
accepts the ubiquitin from the E1 by transthioesterification. The ubiquitin-bound E2 
interacts with the E3 ubiquitin ligase, which ultimately ubiquitinates target protein 
substrates (Streich and Lima, 2014). This step largely divides into two major categories 
of E3s. First, RING (Really New Interesting Gene) E3 ligases act as scaffolds for the 
E2~Ub and substrates, where the ubiquitin directly transfers to the lysine of substrate 
protein. Over 600 E3 ligases are known to be part of the RING family (Deshaies and 
Joazeiro, 2009). Second, HECT (Homologous to E6-AP Carboxyl Terminus) E3 ligases 
also act as scaffolds for the E2~Ub and substrates, but makes a thioester linked E3~Ub 
intermediate, where the Ub from the E2 transfers to the catalytic cysteine of the HECT 
E3, and then sequentially transfers the Ub to the substrate protein via its HECT domain 
(Huibregtse et al., 1995). There is a hybrid type of E3 ligases called RBRs (RING1-in 
between RING-RING2) where it contains RING domains but utilizes HECT 
mechanisms. Overall in the human genome, there are two E1s, tens of E2s, and hundreds 
of E3s that regulate ubiquitination of over thousands of substrates.  
 
 
Cullin RING Ligases 
 
 Cullin RING ligases (CRL), a superfamily of RING E3s, are modular complexes 
composed of a catalytic RING subunit bound to cullin repeats. The RING domain 
interacts with two zinc ions by its cysteine and histidine residues to provide structural 
stability for protein-protein interactions by producing a globular platform (Borden et al., 
1995). Each different cullins have variety of substrate receptors that allow participation 
of cullin RING ligases in majority of cellular processes (Deshaies and Joazeiro, 2009). 
Cul1, Cul2, Cul3, Cul4A, Cul4B, and Cul5 along with their substrate receptors and RING 
box proteins (Rbx) yield around 500 different combinations of cullin RING ligases  
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Figure 1-1. The Ubiquitin Pathway.  
 
Schematic of the ubiquitin pathway. Catalytic cysteine of E1 attacks adenylated 
ubiquitin, producing a highly reactive complex of E1~Ub. By transthioesterification, 
ubiquitin transfers from E1 to E2, and further onto substrate via 3 types of E3 ubiquitin 
ligases: RING, HECT, and RBR.  
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(Zimmerman et al., 2010). Among the CRL family includes the well-known Skp1-Cul1-
F-box (SCF) ubiquitin ligase where the N-terminus of Cul1 binds Skp1, and the C-
terminus binds Rbx1 for E2 interaction. The F-box protein directly binds to Skp1 by the 
F-box domain for substrate specificity (Cardozo and Pagano, 2004). The F-box proteins 
also contain protein-protein interaction motifs such as leucine-rich repeats (LRR) or WD 
repeats (Schulman et al., 2000). By different types of F-box proteins, the cullin RING 
ligases undergo different conformations. For instance, Fbw7 can dimerize Cul1Rbx1 
complex by its D-domain, which is highly conserved in F-box proteins with WD40 repeat 
motifs (Tang et al., 2007). Cul3Rbx1 can also dimerize via MATH-BTB proteins 
(Zhuang et al., 2009).  
 
 
NEDD8ylation 
 
 Many ubiquitin like proteins (Ubl) exist to regulate protein functions. NEDD8 
(neural-precursor-cell-expressed developmentally down-regulated 8), a Ubl, is essential 
for the activity of cullin RING ligases. Human NEDD8 shares 60% sequence identity 
with ubiquitin and has a NEDD8ylation cascade. By its Nedd8 E1 APPBP1-Uba3, Nedd8 
E2 Ubc12, and Nedd8 E3 Rbx1/2, Nedd8 is ultimately attached onto its substrate cullin 
(Huang et al., 2009). With its E3 RING box protein, NEDD8 conjugates onto the cullin 
scaffold lysine that activates the cullin RING ligase (Lydeard et al., 2013). Cullin 
NEDD8ylation enhances E2 recruitment by its selectivity towards ubiquitin charged E2s 
and improves substrate ubiquitination (Saha and Deshaies, 2008). NEDD8 ligation also 
causes a dramatic conformational change of the Cullin Rbx complex so that the E2~Ub 
positions proximally to the substrate lysine (Duda et al., 2008; Scott et al., 2014). DCN1 
also enhances cullin NEDD8ylation as an auxiliary E3 by binding its PONY (potentiating 
NEDD8) domain with Cul1 and Ubc12. NEDD8ylated cullins are deNEDD8ylated by the 
multiprotein complex COP9 signalosome (CSN) (Enchev et al., 2012; Lyapina et al., 
2001). Recent structural studies were able to observe the mechanism of CSN and its 
cullin RING ligase regulation (Cavadini et al., 2016; Mosadeghi et al., 2016). 
DeNEDD8ylation by CSN blocks substrate access and allows substrate receptor 
exchange by CAND1. CAND1 can only bind to the unNEDD8ylated form of cullins and 
this substrate receptor exchange allows cullin RING ligases to be involved in numerous 
substrate ubiquitinations (Pierce et al., 2013; Schmidt et al., 2009).  
 
 
RBR E3 Ligases 
   
 There is a special family of E3 ligases, called RBRs (RING1-in between RING-
RING2). RBRs are reported to be RING/HECT hybrid E3s. Unlike RING E3s, RBRs 
produce an E3~Ub intermediate, where the ubiquitin makes a thioester link on the 
catalytic cysteine of RING2, just as would occur on a HECT E3 (Wenzel et al., 2011). 
RBR E3s contain 3 RING domains each coordinating two zinc ions: RING1, in-between-
RING, and RING2 (Hristova et al., 2009). However, the name today is controversial as 
the RING2 does not have the canonical RING E3 structure with only a single cysteine. So 
far, only 13 human RBRs and 2 yeast RBRs have been identified (Eisenhaber et al., 
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2007). Most studied RBRs include the famous Parkinson’s disease related Parkin, 
LUBAC (linear ubiquitin chain assembly complex), HOIP, HOIL-1L, Cul9, HHARI, and 
Triad1 (Spratt et al., 2014). Studies show that RBRs adopt an autoinhibitory 
conformation, where a specific domain masks the catalytic cysteine of RING2: Ubl 
domain for Parkin and Ariadne domain for HHARI (Chaugule et al., 2011; Duda et al., 
2013; Trempe et al., 2013; Wauer and Komander, 2013). RBRs are also known to interact 
with kinases. PINK1(PTEN induced putative kinase 1) is reported to phosphorylate 
ubiquitin, sequentially activating parkin (Koyano et al., 2014).  
 
 
Human Homolog of Ariadne (HHARI) 
 
Human homolog of Ariadne, HHARI, is an E3 RBR ligase consisting of an N-
terminal acidic/glycine rich domain, UBA domain, RING1, IBR, RING2, and an Ariadne 
domain (Figure 1-2). In recent years, Duda et al were able to solve the crystal structure 
of HHARI, which provides tremendous insight into the mechanism of RBRs. The 
structure explains how HHARI is autoinhibited, as 30% of the RING2 surface including 
the catalytic cysteine is masked by the Ariadne domain (Figure 1-3). In order to study the 
activation of HHARI, Duda et al performed various combinations of mutational analyses, 
and discovered a set of mutations that significantly activates HHARI. Triple mutation of 
F430A, E431A, and E503A significantly activated HHARI by a autoubiquitination assay, 
which is known to be a good measurement of E3 ligase activity (Duda et al., 2013). Seen 
in the structure (PDB ID: 4KBL), all three residues closely interact with the catalytic 
cysteine residue 357, indicating that mutating these residues might facilitate opening of 
the RING2 for ubiquitin access.  
 
 
Interaction Between HHARI and Cullin RING Ligase 
 
 Kelsall et al screened combinations of two E3 ligases, one RBR and one RING, 
for activity. With several combinations, they found that NEDD8ylated cullin RING 
ligases and RBRs have interaction, specifically the two members of the Ariadne 
subfamily HHARI and TRIAD. Autoubiquitination assays show that adding 
NEDD8ylated Cul1Rbx1 activated wild type HHARI significantly, which is normally 
autoinhibited (Kelsall et al., 2013). NEDD8ylation of cullin RING ligase is essential for 
the activity of CRLs, and Kelsall et al were able to discover that only the NEDD8ylated 
cullin RING ligases activate HHARI, and the unmodified form of CRLs have no effect. 
In fact, modification of CRL by the ubiquitin like protein NEDD8 causes dramatic 
reorientation of the structure allowing conformations capable of substrate 
polyubiquitination (Duda et al., 2008). The interaction between these two types E3 
ligases opens up possibilities of a whole new mechanism of the function of E3s. In fact, 
another type of RBR Parc is known to be a fused form of Cul7 and an RBR Ariadne 
gene, which indicates that interaction of cullins and HHARI might have specific 
functions (Skaar et al., 2007).  
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Figure 1-2. Human Homologue of Ariadne.  
 
(A) Domains of HHARI, human homolog of Ariadne. HHARI has an Acidic/Gly rich 
domain, UBA domain, RING1, IBR, RING2, and an inhibitory Ariadne domain. (B) 
Structure of HHARI. The Ariadne domain covers about 30% of RING2, containing the 
catalytic site. Circles in yellow indicate zinc ions.  
 
Data source: DOI: 10.2210/pdb4kbl/pdb 
Duda, D.M., Olszewski, J.L., Schuermann, J.P., Kurinov, I., Miller, D.J., Nourse, A., 
Alpi, A.F., and Schulman, B.A. (2013). Structure of HHARI, a RING-IBR-RING 
Ubiquitin Ligase: Autoinhibition of an Ariadne-Family E3 and Insights into Ligation 
Mechanism. Structure 21, 1030-1041. 
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Figure 1-3. FEE Mutation of HHARI.  
 
Sites of FEE mutation of HHARI. F430A, E431A, and E503A are sites closely related to 
the catalytic cysteine C357. Circles in yellow indicate zinc ions.  
 
Data Source: DOI: 10.2210/pdb4kbl/pdb 
Duda, D.M., Olszewski, J.L., Schuermann, J.P., Kurinov, I., Miller, D.J., Nourse, A., 
Alpi, A.F., and Schulman, B.A. (2013). Structure of HHARI, a RING-IBR-RING 
Ubiquitin Ligase: Autoinhibition of an Ariadne-Family E3 and Insights into Ligation 
Mechanism. Structure 21, 1030-1041. 
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Based on these evidences, my primary goal is to study this complex of two E3 
ligases structurally to understand its mechanism. As technology for electron microscopy 
is on its prime time of development, I can take advantage of this to study the structural 
interaction between the two proteins. Now, electron microscopy can produce 3D images 
of macromolecules with resolutions close to that of X-ray crystallography or NMR 
spectroscopy. Another groundbreaking technology of EM microscopy called GraFix, 
which artificially fixes a complex during ultracentrifugation will facilitate greatly in 
trying to stabilize the complex during electron microscopy. Capturing the NEDD8ylated 
cullin and HHARI in action, along with the E2 and a potential substrate reveal the 
molecular basis for a fundamentally novel mechanism of E3 ligases.  
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CHAPTER 2.    METHODS 
 
 
Protein Expression and Purification 
 
 All proteins used correspond to human sequences. Full length HHARI and 
F430A, E431A, E503A triple mutant were both cloned into pGEX4T1 (GE) modified 
with a TEV proteolytic cleavage site following GST. HHARI wt and FEE clones were 
transformed to BL21 (DE3) Gold competent cells for expression in E.coli. Cultures were 
grown in LB media in the presence of antibiotics at 37°C shaking at 200 rpm. At O.D. of 
0.8, cells were induced with 0.6mM IPTG (isopropyl beta-D-thiogalactopyranoside) and 
grown overnight at 16°C. Proteins were purified by glutathione affinity chromatography, 
followed by overnight TEV proteolysis at 4°C to separate HHARI and GST. HHARI was 
purified away from GST by anion exchange with a 5ml High trap Q column (GE), and 
further purified by size exclusion chromatography in buffer conditions of 25mM HEPES 
pH 7.5, 150mM NaCl, 1mM DTT. After size-exclusion chromatography, proteins were 
pooled, concentrated, flash-frozen, and stored at -80°C. UbcH7, Uba1, and ubiquitin 
used in the autoubiquitination assays along with APPBP1-Uba3, Ubc12, and Nedd8 used 
in NEDD8ylation reactions were prepared in a similar manner.  
 
 Constructs of full-length Cul1 and Rbx1 were cloned into pFastBac vectors, with 
untagged Cul1 and TEV cleavable GST-TEV-Rbx1. Baculoviruses were made with 
bacmid DNA transformed into DH10alpha, and were amplified in Sf9 insect cells. Cul1 
and Rbx1 was coexpressed in High Five insect cells, using viruses of Cul1 and GST-
Rbx1. Cul1Rbx1 was purified by glutathione affinity chromatography, followed by 
overnight TEV proteolysis at 4°C. Further purification was done by cation exchange with 
5ml High trap S column, and size-exclusion chromatography in buffer conditions of 
25mM HEPES pH 7.5, 150mM NaCl, 1mM DTT. After size exclusion-chromatography, 
proteins were pooled, concentrated, and flash-frozen, and stored at -80°C.  
 
 
Biochemical Reactions and Assays 
 
 NEDD8ylation reactions of Cul1Rbx1 and Cul3Rbx1 were done by incubating 
100nM APPBP1-Uba3, 1µM Ubc12, 12µM Cul1Rbx1, 25µM Nedd8, in 25mM HEPES 
pH 7.8, 100mM NaCl, 2.5mM MgCl2, 1mM ATP, for 9 min at room temperature. The 
reaction was done in 2ml volume, quenched with 10mM DTT. Sample was spun down 
13,000rpm for 10 min and further purified by size-exclusion chromatography in 25mM 
HEPES pH 7.5, 150mM NaCl, 1mM DTT.  
 
 Autoubiquitination reactions were performed by incubating 200nM Uba1, 1µM 
UbcH7, 20µM Ubiquitin, 400nM HHARI, ±400nM N8Cul1Rbx1/N8Cul3Rbx1 in 50mM 
Tris-HCl pH 7.6, 50mM NaCl, 10mM MgCl2, 5mM ATP at room temperature, and was 
quenched with 2X SDS-PAGE sample buffer containing 20mM DTT each time point. 
For reactions containing N8Cul1Rbx1/N8Cul3Rbx1, cullins were preincubated with 
HHARI for 20 min on ice. Reactions were initiated by adding Uba1 and were run on 4%-
 9 
12% gradient gels (Invitrogen), stained overnight by SYPRO-Ruby stain, and visualized 
by a Typhoon gel-imager.  
 
 
Analytical Size-Exclusion Chromatography 
 
 Analytical size-exclusion chromatography was used to examine association 
between HHARI and NEDD8ylated cullin RING ligases. Proteins were mixed at 
equimolar concentrations of 10µM in 200µl volumes on ice for 30 min. Each mix was 
spun down at 13000 rpm for 10 minutes and loaded onto a SD200 10/300 column (GE), 
in buffer conditions of 25mM HEPES pH 7.5, 100mM NaCl, 1mM DTT. 500µl fractions 
were collected and run on 10% SDS gels, and visualized by Coomassie staining.  
 
 
GraFix and Negative Staining 
 
Protein samples were mixed at equimolar concentrations of 10µM in 100µl. 
N8Cul1Rbx1, Skp1Fbw7, HHARI FEE mutant were mixed on ice for 30 min. The 
sample was spun down 35,000rpm for 15 hr in a 5ml 10%-30% (w/v) sucrose gradient 
made by 25mM HEPES pH 7.5, 200mM NaCl, 1mM DTT. The sucrose gradient 
contained 0.05% gluteraldehyde for fixation. 205µl fractions were taken from the top and 
mixed with 5µl of 0.5M Sodium Aspartate pH 8.0 for each fraction. Fractions were 
measured with 1x Biorad protein assay on a 96well plate, and desired fractions were 
collected and flash frozen before use. 30µl of each fraction were used for making 
negative stain grids and fixed with 2% Uranyl acetate on carbon film.  
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CHAPTER 3.    RESULTS 
 
 
NEDD8ylated Cullin RING Ligases Activate HHARI 
 
I sought to understand the mechanisms of how E3 ligases gain activity, 
specifically RBR type E3 ligases. Studies by Duda et al gave us insight into how the 
F430A, E431A, E503A triple mutation helps activate HHARI. Further studies from 
Kelsall et al showed that adding NEDD8ylated cullin RING ligase results in HHARI 
activity. It might be possible that the interaction between the two E3 ligases might 
produce an entire new form of E3 that has its own certain mechanism for substrate 
ubiquitination. Therefore, I first tested whether the FEE mutation enhances interaction 
with the NEDD8ylated cullins by looking at the autoubiquitination activity of HHARI. 
HHARI FEE clearly showed activity compared to wild type HHARI by formation of 
ubiquitin chains on HHARI (Figure 3-1A). Adding either NEDD8ylated Cul1Rbx1 or 
Cul3Rbx1 both slightly activated HHARI WT. As HHARI FEE activates so quickly, 
there is not a noticeable difference in autoubiquitination when NEDD8ylated cullins are 
added (Figure 3-1B, C). However, it was clear from the wild type activation that the 
NEDD8ylated cullins influence HHARI activation.  
 
 
NEDD8ylated Cullin RING Ligases Bind with HHARI 
 
In order to understand how the NEDD8ylated cullin RING ligases interact with 
HHARI, I performed analytical size exclusion chromatography to assess complex 
formation. If the interaction enhances HHARI activity, it is possible that the two proteins 
have structural interaction. First, the complex formed with wild type HHARI and 
N8Cul1Rbx1 produced a higher molecular weight complex, but also produced a big 
shoulder peak that seemed to have a partial product. However, HHARI FEE and 
N8Cul1Rbx1 made a larger complex, with a smaller shoulder peak (Figure 3-2A). Seen 
by coomassie staining of gels run on same fractions, both WT or FEE HHARI make a 
complex with N8Cul1Rbx1, but the FEE complex makes a larger form of almost two 
fractions (Figure 3-2B). This suggests that it is possible the HHARI FEE makes a tighter 
complex with N8Cul1Rbx1 compared to HHARI WT.  
 
An analogous experiment showed that N8Cul3Rbx1 also helps activate HHARI 
WT on its autoubiquitination. However, surprisingly there were no differences between 
the sizes of the complexes made between N8Cul3Rbx1 and HHARI WT or HHARI FEE 
(Figure 3-3A, B). Therefore, the N8Cul3Rbx1 did not differentiate whether HHARI has 
the FEE mutation or not. Overlap of all peaks showed that the largest complex made was 
between N8Cul1Rbx1 and HHARI FEE (Figure 3-3C).  
 
  
 11 
 
 
Figure 3-1. FEE Mutation of HHARI and the Addition of N8Cul1Rbx1 Both 
Activate HHARI.  
 
(A) WT HHARI stays inactivate as no autoubiquitin chains are built by time. However, 
FEE mutation of HHARI induces autoubiquitination activity starting from 0.5 min 
building autoubiquitin chains, and almost fully saturated by 5min. (B) N8Cul1Rbx1 
promotes wild type HHARI activation, while enhancing the activity of HHARI FEE 
mutant. (C) N8Cul3Rbx1 also promotes wild type HHARI activation, while enhancing 
the activity of HHARI FEE mutant. All assays are observed by SYPRO-Ruby staining.  
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Figure 3-2. Analytical Size-Exclusion Chromatography Shows Interaction 
Between N8Cul1Rbx1 and HHARI.  
 
(A) Wild type HHARI forms a complex with N8Cul1Rbx1, but makes a big shoulder 
peak of an intermediate complex. HHARI FEE mutant forms a larger complex with 
almost very little intermediate product, indicating equilibrium shifting more towards 
complex formation. (B) Overlay of two complexes made either by wild type or FEE 
mutant HHARI. FEE mutant clearly makes a better complex with N8Cul1Rbx1.  
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Figure 3-3. Interaction Between N8Cul3Rbx1 and HHARI. 
  
(A) Both wild type and FEE mutant HHARI forms a complex with N8Cul3Rbx1 in a 
similar manner, making similar shoulder intermediates. (B) Overlay of two complexes 
made either by wild type or FEE mutant HHARI. They are identical. (C) Overall overlay 
all type of complexes. N8Cul1Rbx1 and HHARI FEE form the largest complex with the 
least intermediate.  
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GraFix and Negative Staining 
 
We sought to study the newly formed complex by structural studies. However, 
due to the current limits of electron microscopy, a protein complex of less than 200 kDa 
would not produce an ideal resolution. I tried to enhance contrast by making the complex 
bigger by adding an adaptor protein of N8Cul1Rbx1. Skp1Fbw7 is a substrate adaptor 
protein of N8Cul1Rbx1 that dimerizes, suggesting the entire complex might be able to 
dimerize by Skp1Fbw7. However, adding Skp1Fbw7 to HHARI FEE and N8Cul1Rbx1 
did not form a large complex when analyzed over size-exclusion chromatography (figure 
not shown). Therefore, another way to generate a robust complex was to artificially trap 
it. GraFix, a well known technique used to chemically lock a protein complex, was used 
for making samples for electron microscopy (Kastner et al., 2008). This allowed me to 
make a complex that contain all three proteins, HHARI FEE, N8Cul1Rbx1, and 
Skp1Fbw7, possibly in a dimer form. The percentage of gluteraldehyde added, speed and 
time of centrifugation were optimized, calculated by the theoretical molecular weight. 
The peaks of Biorad protein assay traveled to an optimal fraction after ultracentrifugation 
(Figure 3-4A).  
 
Negative staining of samples of Fraction#18 produced semi-homogenous 
molecular images (Figure 3-4B). We can definitely see the multiple circular shapes with 
a hollow center, and cryo EM is currently in progress. If the results produce a high 
resolution 3D image, it will give tremendous information on structural interaction 
between NEDD8ylated cullins and RBRs.  
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Figure 3-4. Electron Microscopy of HHARI FEE, N8Cul1Rbx1, and Skp1/Fbw7. 
 
(A) 10-30% (w/v) sucrose gradient ultracentrifugation fraction profile with or without 
0.05% Gluteraldehyde. Fraction#18 was used for negative staining. (B) Negative stain 
image of Fraction#18 of complex with HHARI FEE, N8Cul1Rbx1, and Skp1/Fbw7.  
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CHAPTER 4.    DISCUSSION 
 
 
Here, I studied the interaction between two E3 ligases, HHARI and N8Cul1Rbx1. 
I showed that NEDD8ylated cullin RING ligases are able to make a complex with 
HHARI. A specific set of HHARI mutations, F430A, E431A, and E503A, was not only 
able to activate its autoubiquitination, but also produce a complex with N8Cul1Rbx1. 
Understanding the mechanism of the two E3 ligases’ interaction may reveal a novel 
mechanism of the ubiquitin pathway and providing structural insights will be the key. 
 
 
Microscopic Reversibility of Protein Complex 
 
Microscopic reversibility states that there is always a reverse reaction by time, 
therefore a heterogenous substance can constantly exist in subgroups composed of 
intermediate states for every process (Lewis, 1925). So far, the biggest challenge in our 
efforts to make a stable complex with HHARI and N8Cul1Rbx1 was that whenever the 
complex was run on size exclusion chromatography, it would produce a 70% bound 
form, with a shoulder peak that would indicate an unbound form or an intermediate. This 
resulted in many attempted failures on trying to crystallize the complex, and the crystals 
obtained were only one part of the complex, either HHARI or NEDD8ylated Cul1Rbx1. 
Therefore the microscopic reversibility of the complex of N8Cul1Rbx1 and HHARI WT 
has been an issue as the constant association and dissociation produced an unstable 
complex suitable for crystal formation. If we are able to somehow shift the equilibrium to 
where it is more favorable in a bound form, that would enable us to study its structure 
either through crystallography or electron microscopy.  
 
 
Stabilizing the Complex 
 
 From preliminary studies (not shown), we know that the N-terminal 90 residues 
of HHARI, which are highly acidic and glycine rich, are necessary for binding to 
N8Cul1Rbx1. I believe the acidic regions are capable of making interactions but the 
abundance of glycines makes the structure not stable enough for a single, specific 
interaction. Therefore, this might be the reasoning behind the dynamic equilibrium state, 
producing intermediate products. It was surprising to find out that introducing the F430A, 
E431A, E503A triple mutation of HHARI was able to make a larger complex from size 
exclusion chromatography, while having a very little shoulder peak. This indicated that 
the equilibrium greatly shifted to the complex formation side and producing less 
intermediate forms than previous experiments. It is possible that the triple mutation opens 
up a secondary docking site for the NEDD8ylated cullin to bind. With the equilibrium 
shift, I was able to gain confidence that HHARI FEE form a much more stable complex 
compared to HHARI WT.  
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Ub-VME as a Chemical Warhead 
 
 Chemically modified ubiquitins were initially introduced as probes for reactivity 
of deubiquitinating enzymes (DUB) (Borodovsky et al., 2002). In previous studies of 
Parkin, chemically modified ubiquitin-vinyl sulfone (Ub-VS) was implemented as a 
probe that covalently modifies the catalytic cysteine of Parkin without the help of E2 
(Riley et al., 2013). Kelsall et al also implemented an electrophilic Ubiquitin-vinyl 
methyl ester (Ub-VME) to find that the Ub-VME binds to the catalytic cysteine of 
HHARI by either removing the Ariadne domain or the addition of NEDD8ylated cullins 
(Kelsall et al., 2013). In fact, there have been structural studies using the Ub-VME to 
study molecular contacts for ubiquitin recognition (Sheedlo et al., 2015). Implementing 
Ub-VME on structural studies of the complex with NEDD8ylated cullins and HHARI 
will have a modified ubiquitin bound to the active site cysteine, producing an active form 
of the complex. Further on, if this active site bound Ub-VME interacts with multiple sites 
on either HHARI or NEDD8ylated cullin, it can act as a chemical linker that locks the 
complex in action. 
 
 
Targets for Electron Microscopy 
 
 Currently, size is a very important factor in achieving high-resolution 3D images 
for electron microscopy. Therefore, dimerizing the complex would significantly improve 
EM studies. F-box protein Fbw7 of Cul1Rbx1 would theoretically produce a dimer. Also, 
Cul3Rbx1 binds with a BTB protein that is known to interact with substrate adaptors. 
Most importantly they are known to dimerize (Furukawa et al., 2003; Zhuang et al., 
2009). As Cul3Rbx1 also interacts with HHARI, dimerization of Cul3Rbx1 and its 
substrate adaptor will likely cause dimerization of the potentially HHARI bound complex 
as well, producing a sizable protein suitable for electron microscopy. However, according 
to the analytical size-exclusion chromatography experiments (Figure 6B), N8Cul3Rbx1 
did not make a difference in the interaction between either HHARI WT or FEE mutant. 
Therefore, it is not clear whether N8Cul3Rbx1 would interact in a similar way with 
N8Cul1Rbx1, but it will definitely give insight towards how the cullin RING ligases 
interact with HHARI.  
 
According to protein interaction studies, HHARI is seen to interact with Cul1, 
Cul2, Cul3, and Cul4A, which can also be tried for structural studies. Another Ariadne 
family protein TRIAD1 can also be used, as Kelsall et al used to study interactions with 
Cul5. One option to study a complex between RBR and cullins would be Parc (Cul9) as 
this is known as a cullin and Ariadne RBR fused protein. So far, there have been no 
structural studies on this protein, which can potentially provide great insight on the cullin 
RBR complex. From these studies I hope to learn a novel mechanism of two different E3 
ligases working together. It is possible that the study might reveal a new category of E3 
ligases, as there have been no studies on this interaction mechanism. Further on, as an E3 
ligase, its substrate regulation will be most important in its participation in cellular 
processes. It will be interesting to study what this new complex regulates downstream, 
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whether it will affect substrates of NEDD8ylated cullins, HHARI, or affect entirely new 
substrates.   
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